SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005286-24-000039
Filing Date
2024-03-26
Accepted
2024-03-26 16:32:05
Documents
15
Period of Report
2024-03-20
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20240320.htm   iXBRL 8-K 34019
2 EX-16.1 lifecoreitem401ex161letter.htm EX-16.1 4731
6 imagea.jpg GRAPHIC 9121
  Complete submission text file 0001005286-24-000039.txt   177933

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20240320.xsd EX-101.SCH 1983
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20240320_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20240320_pre.xml EX-101.PRE 12591
18 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20240320_htm.xml XML 2690
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 24784099
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)